Renal and Nonrenal 25-Hydroxyvitamin D-1α-Hydroxylases and Their Clinical Significance
- 1 March 1998
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 13 (3) , 350-353
- https://doi.org/10.1359/jbmr.1998.13.3.350
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Diagnostic Criteria of Vitamin D DeficiencyThe Endocrinologist, 1993
- Increased calcium intake does not suppress circulating 1,25-dihydroxyvitamin D in normocalcemic patients with sarcoidosis.Journal of Clinical Investigation, 1993
- Expression of 25‐hydroxyvitamin D 24‐hydroxylase cytochrome P450 in kidney and intestine Effect of 1,25‐dihydroxyvitamin D and ageFEBS Letters, 1991
- Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate.Journal of Clinical Investigation, 1986
- Tight Regulation of Circulating 1α,25-Dihydroxyvitamin D in Black ChildrenNew England Journal of Medicine, 1985
- Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man.Journal of Clinical Investigation, 1984
- Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children.Journal of Clinical Investigation, 1981
- Hypercalcemia in an Anephric Patient with Sarcoidosis: Evidence for Extrarenal Generation of 1,25-Dihydroxyvitamin DNew England Journal of Medicine, 1981
- Intestinal Calcium Absorption and Serum Vitamin D Metabolites in Normal Subjects and Osteoporotic PatientsJournal of Clinical Investigation, 1979
- Evidence that Increased Circulating 1α,25-Dihydroxyvitamin D is the Probable Cause for Abnormal Calcium Metabolism in SarcoidosisJournal of Clinical Investigation, 1979